Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Lobular Carcinoma In Situ”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04046159
What this trial is testing

Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ

Who this might be right for
Breast Ductal Carcinoma in Situ
National Taiwan University Hospital 810
Not applicableEnded earlyNCT00556907
What this trial is testing

Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast

Who this might be right for
Breast Cancer
University of Southern California 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT04009044
What this trial is testing

Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast

Who this might be right for
Cancer SurvivorDuctal Breast Carcinoma In SituInvasive Breast Carcinoma
Northwestern University 156
Early research (Phase 1)Looking for participantsNCT06218303
What this trial is testing

Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

Who this might be right for
Ductal Carcinoma in Situ
Finn, Olivera, PhD 50
Large-scale testing (Phase 3)Study completedNCT00004205
What this trial is testing

Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 8,028
Testing effectiveness (Phase 2)Study completedNCT00182793
What this trial is testing

Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 32
Large-scale testing (Phase 3)Study completedNCT00438659
What this trial is testing

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

Who this might be right for
Breast CancerDermatologic ComplicationsRadiation Toxicity+1 more
North Central Cancer Treatment Group 176
Not applicableActive Not RecruitingNCT03546972
What this trial is testing

Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants

Who this might be right for
Deleterious BRCA1 Gene MutationDeleterious BRCA2 Gene MutationDuctal Breast Carcinoma In Situ+3 more
M.D. Anderson Cancer Center 51
Testing effectiveness (Phase 2)Study completedNCT03345420
What this trial is testing

Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer

Who this might be right for
Ductal Breast Carcinoma In SituInvasive Breast CarcinomaStage 0 Breast Cancer+6 more
University of Utah 102
Testing effectiveness (Phase 2)Study completedNCT00354640
What this trial is testing

Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 11
Testing effectiveness (Phase 2)Ended earlyNCT00290654
What this trial is testing

Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ

Who this might be right for
Breast Cancer
Masonic Cancer Center, University of Minnesota 45
Very early researchEnded earlyNCT01138553
What this trial is testing

Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer

Who this might be right for
Invasive Breast CancerDuctal Carcinoma in Situ
University of California, San Diego 4
Not applicableStudy completedNCT05012176
What this trial is testing

An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8+21 more
Ohio State University Comprehensive Cancer Center 50
Not applicableLooking for participantsNCT06903468
What this trial is testing

Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions

Who this might be right for
Ductal Carcinoma in SituBreast Cancer
University of Florida 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05591547
What this trial is testing

Evaluating the Safety and Efficacy of a Novel Accelerated Partial Breast Irradiation Regimen

Who this might be right for
Breast Cancer
Sanford Health 91
Not applicableNot Yet RecruitingNCT06860217
What this trial is testing

Robotic Nipple Sparing Mastectomy with Immediate Reconstruction

Who this might be right for
Breast CancerDCISBRCA Mutation
European Institute of Oncology 24
Testing effectiveness (Phase 2)Ended earlyNCT01754519
What this trial is testing

Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery

Who this might be right for
Ductal Breast Carcinoma In SituEstrogen Receptor NegativeEstrogen Receptor Positive+12 more
Roswell Park Cancer Institute 1
Not applicableWithdrawnNCT05032079
What this trial is testing

Subzero and Scorpion Trial

Who this might be right for
Ductal Carcinoma in Situ
Larkin Community Hospital
Not applicableUnknownNCT01034891
What this trial is testing

Women At Risk: The High Risk Breast Cancer Program

Who this might be right for
Breast Cancer
New York Presbyterian Hospital 2,000
Early research (Phase 1)Study completedNCT00245024
What this trial is testing

Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 30
Next Page